Walaa Abbas Adly Abbas

Ms. Walaa Abbas Adly Abbas

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2021 in Langmuir
Verified
Journal Article
Closed access
WAWalaa Abbas Adly Abbas
Walaa Abbas Adly Abbas
BSBasamat S. Shaheen
Basamat S. Shaheen
LGLoujain G. Ghanem
Loujain G. Ghanem
IBIbrahim M. Badawy
Ibrahim M. Badawy
MAMohamed M. Abodouh
Mohamed M. Abodouh
Nageh K AllamNageh K Allam
Nageh K Allam

16 November 2020 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
WAWalaa Abbas Adly Abbas
Walaa Abbas Adly Abbas
MIMaha E. Ibrahim
Maha E. Ibrahim
MEManar El-Naggar
Manar El-Naggar
WAWessam A. Abass
Wessam A. Abass
IAIbrahim H. Abdullah
Ibrahim H. Abdullah
Nageh K AllamNageh K Allam
Nageh K Allam

7 February 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RNRoua Aref Nouh
Roua Aref Nouh
AKAhmed Kamal
Ahmed Kamal
OOOluwaseyi Oyewole
Oluwaseyi Oyewole
WAWalaa Abbas Adly Abbas
Walaa Abbas Adly Abbas
BABishoy Fayez Abib
Bishoy Fayez Abib
AAAnwar Abdelnaser
Anwar Abdelnaser
Multiple sclerosis is the predominant autoimmune disorder affecting the central nervous system in adolescents and adults. Specific treatments are categorized as disease-modifying, whereas others are symptomatic treatments to alleviate painful symptoms. Currently, no singular conventional therapy is universally effective for all patients across all stages of the illness. Nevertheless, cannabinoids exhibit significant promise in their capacity for neuroprotection, anti-inflammation, and immunosuppression. This review will examine the traditional treatment for multiple sclerosis, the increasing interest in using cannabis as a treatment method, its role in protecting the nervous system and regulating the immune system, commercially available therapeutic cannabinoids, and the emerging use of cannabis in nanomedicine. In conclusion, cannabinoids exhibit potential as a disease-modifying treatment rather than merely symptomatic relief. However, further research is necessary to unveil their role and establish the safety and advancements in nano-cannabinoid medicine, offering the potential for reduced toxicity and fewer adverse effects, thereby maximizing the benefits of cannabinoids.

26 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
PRPunsasi Rajakaruna
Punsasi Rajakaruna
Stella Aimé RiosStella Aimé Rios
Stella Aimé Rios
HEHana Elnahas
Hana Elnahas
AVAshley Villanueva
Ashley Villanueva
DUDavid Uribe
David Uribe
Megan KeniryMegan Keniry
Megan Keniry
In this review, we discuss how mutations in glioma are associated with prognosis and treatment efficacy. A fascinating characteristic of glioma and all cancers is that while common growth and developmental pathways are altered, the characteristic mutations are distinct depending on the specific type of tumor with concomitant prognoses. Next-generation sequencing, precision medicine, and artificial intelligence are boosting the employment of molecular biomarkers in cancer diagnosis and treatment. Understanding the biological underpinnings of distinct mutations on critical signaling pathways is crucial for developing novel therapies for glioma.